Press Releases

Nomination of Christophe Maréchal as interim CEO
21 January 2021
EN FR

Mithra Announces 2021 Financial Calendar
12 January 2021
EN FR

Richter and Mithra strengthen their partnership and signed a license and supply agreement for the commercialization of Estelle® to Latin America
23 December 2020
EN FR

Mithra Announces Positive DSMB Safety Review and Continuation of its Phase III Clinical Program Donesta® in menopause
16 December 2020
EN FR

Mithra announces final terms of its offering of EUR 125 million convertible bonds due 2025
10 December 2020
EN FR

Mithra announces placement of EUR 125 million convertible bonds due 2025
10 December 2020
EN FR

Mithra launches an offering of up to EUR 150 million convertible bonds due 2025
10 December 2020
EN FR

Scientific community convinced of Estetrol’s potential for women’s health
3 December 2020
EN FR

Mithra’s exclusivity on Estetrol applications extended to 2036 in Europe
30 November 2020
EN FR

Estetrol recognized as a “New Active Substance” by the European Medicines Agency (EMA)
25 November 2020
EN FR

Creation of a New Share Option Plan in Replacement of the 2018 Share Option Plan
20 November 2020
EN FR

E4/DRSP, a Novel Combined Oral Contraceptive, submitted to Brazilian regulatory authorities
17 November 2020
EN FR